StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
TCRT

Alaunos Therapeutics, Inc.

TCRT Nasdaq Pharmaceutical Preparations EDGAR ↗
$1.91
+0.03 +1.33%

Key statistics

from XBRL data in SEC filings
Market cap
$46.5M
Revenue (TTM)
$3.00K
Net income (TTM)
-$4.11M
EPS (TTM)
$-2.12
P/E ratio
Dividend yield
Free cash flow
-$2.97M
Cash
$354K
Total assets
$1.88M
Gross margin
52-week range
$1.67 – $4.59

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Other events Jun 29, 2026 8-K Other events May 26, 2026 8-K Other events May 18, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 8-K Delisting notice or listing-rule failure Apr 15, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Other events Mar 2, 2026 8-K Terminated a material agreement; Modified rights of security holders; Other events Jan 8, 2026 8-K Other events Dec 23, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Other events Aug 20, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Director or officer change Jul 22, 2025 8-K Director or officer change Jul 17, 2025 8-K Modified rights of security holders; Shareholder vote results Jul 10, 2025 8-K Delisting notice or listing-rule failure; Director or officer change Jul 2, 2025 8-K Entered a material agreement; Regulation FD disclosure Jun 26, 2025 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws Jun 26, 2025 8-K Entered a material agreement; Unregistered sale of equity Jun 10, 2025 8-K Entered a material agreement; Unregistered sale of equity May 23, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 30, 2025 8-K Director or officer change Apr 18, 2025 8-K Director or officer change Apr 15, 2025 8-K Entered a material agreement; Terminated a material agreement; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws Apr 14, 2025 8-K Delisting notice or listing-rule failure; Other events Apr 11, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Terminated a material agreement; Results of operations (earnings release) Oct 10, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K/A Modified rights of security holders; Amended charter or bylaws Jul 17, 2024 8-K/A Other events Jul 17, 2024 8-K Amended charter or bylaws Jul 16, 2024 8-K Other events Jul 16, 2024 8-K Changed accountants Jun 21, 2024 8-K Modified rights of security holders; Amended charter or bylaws; Shareholder vote results Jun 12, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 10-K Fiscal year ended 2023-12-31 Apr 1, 2024 8-K Director or officer change Feb 22, 2024